Page 169 - Glucose Monitoring Devices

170 CHAPTER 8 Accuracy of CGM systems

[32] Kovatchev BP, Patek SD, Ortiz EA, et al. Assessing sensor accuracy for non-adjunct
use of continuous glucose monitoring. Diabetes Technology and Therapeutics 2015;
17:177e86.
[33] Facchinetti A, Sparacino G, Guerra S, et al. Real-time improvement of continuous
glucose monitoring accuracy: the smart sensor concept. Diabetes Care 2013;36:
793e800.
[34] Peyser TA, Nakamura K, Price D, et al. Hypoglycemia accuracy and improved low
glucose alerts of the latest Dexcom G4 Platinum continuous glucose monitoring
system. Diabetes Technology and Therapeutics 2015;17. https://doi.org/10.1089/
dia.2014.0415.
[35] Kovatchev BP. Hypoglycemia reduction and accuracy of continuous glucose
monitoring. Diabetes Technology and Therapeutics 2015;17. https://doi.org/10.1089/
dia.2015.0144.
[36] Heise T, Koschinsky T, Heinemann L, Lodwig V. Glucose monitoring study group.
Hypoglycemia warning signal and glucose sensors: requirements and concepts. Dia-
betes Technology and Therapeutics 2003;5:563e71.
[37] Bode B, Gross K, Rikalo N, Schwartz S, Wahl T, Page C, Gross T, Mastrototaro J.
Alarms based on real-time sensor glucose values alert patients to hypo- and
hyperglycemia: the guardian continuous monitoring system. Diabetes Technology
and Therapeutics 2004;6:105e13.
[38] McGarraugh G, Bergenstal R. Detection of hypoglycemia with continuous interstitial
and traditional blood glucose monitoring using the FreeStyle Navigator continuous
glucose monitoring system. Diabetes Technology and Therapeutics 2009;11:145e50.
[39] Buckingham B, Cobry E, Clinton P, Gage V, Caswell K, Kunselman E, Cameron F,
Chase HP. Preventing hypoglycemia using predictive alarm algorithms and insulin
pump suspension. Diabetes Technology and Therapeutics 2009;11:93e7. PMID:
19848575.
[40] Battelino T, Nimri R, Dovc K, Phillip M, Bratina N. Prevention of hypoglycemia with
predictive low glucose insulin suspension in children with type 1 diabetes: a randomized
controlled trial. Diabetes Care 2017;40:764e70. PMID: 28351897.
[41] Pinsker JE, Dassau E. Predictive low-glucose suspend to prevent hypoglycemia. Dia-
betes Technology and Therapeutics 2017;19:271e6. PMID: 28426238.
[42] Breton MD, Patek SD, Lv D, Schertz E, Robic J, Pinnata J, Kollar L, Barnett C,
Wakeman C, Oiveri M, Fabris C, Chernavvsky D, Kovatchev BP, Anderson SM. Contin-
uous glucose monitoring and insulin informed advisory system with automated titration
and dosing of insulin reduces glucose variability in type 1 diabetes mellitus. Diabetes
Technology and Therapeutics 2018;20:531e40. PMID: 29979618.
[43] Bergenstal RM, et al. Safety of a hybrid closed-loop insulin delivery system in patients
with type 1 diabetes. Journal of the American Medical Association 2016;316:1407e8.
PMID: 27629148.
[44] Kovatchev BP. The artificial pancreas in 2017: the year of transition from research to
clinical practice. Nature Reviews Endocrinology 2018;14:74e6. PMID: 29286043.
[45] Brown S, Raghinaru D, Emory E, Kovatchev BP. First look at control-IQ: a new-
generation automated insulin delivery system. Diabetes Care October 10, 2018:
dc181249. PMID: 30305346.
[46] Kovatchev BP. Automated closed-loop control of diabetes: the artificial pancreas.
Bioelectronic Medicine 2018;4:14. https://doi.org/10.1186/s42234-018-0015-6.